What's new

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised

May 23, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sod...

Next Article

European Medicines Agency's data protection notice for selection and recruitment

Related Posts

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0